Chmp News
Most Popular Chmp Story
Glaxo pulls its EU app for rare disease therapy
GlaxoSmithKline says it reluctantly decided to pull its EU application for Bosatria (mepolizumab) after concluding that it didn't have the kind of efficacy data needed to make its case that the drug... Read more...
Latest Headlines
- July 29, 2009
- July 25, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
